Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 07-30-2011, 08:40 AM #1
CarolynS CarolynS is offline
Member
 
Join Date: Nov 2008
Location: Corning NY
Posts: 304
15 yr Member
CarolynS CarolynS is offline
Member
 
Join Date: Nov 2008
Location: Corning NY
Posts: 304
15 yr Member
Default Predicting Dementia With New Parkinson's Test

Predicting Dementia With New Parkinson's Test

Denver, Colorado, POSTED: 4:30 pm MDT July 29, 2011

RESEARCH SUMMARY

Background: Parkinson's disease is a disorder that affects nerve cells in the portion of the brain that controls muscle movement. These nerve cells create a chemical called dopamine, which will die or stop functioning properly. Dopamine is significant to the body because it sends signals from the brain to help coordinate movement. Parkinson's patients often experience a series of symptoms such as tremors, rigid movements, and loss of mental functions. As symptoms worsen, people with the disease may have trouble walking, talking or performing simple tasks. They may also have problems such as depression, sleep deprivation or trouble chewing, swallowing or speaking. Parkinson's is one of a larger group of neurological conditions known as motor system disorders. Historians say the disease dates back as far as 5000 B.C. It was first described as "the shaking palsy" in 1817 by British doctor James Parkinson. (SOURCE: www.parkinsons.org)

Physical And Mental Impact
: Parkinson's disease affects one in every 100 Americans over the age of 60. Along with its debilitating physical effects, many patients will develop mental decay. Studies are suggesting that a protein in the blood may confirm which patients have the highest risk of developing dementia.

New Test: Researchers at the University of Pennsylvania School of Medicine examined 150 different proteins in the blood. They found one called epidermal growth factor, or EGF, may predict a patient's cognitive function. EGF is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation. Patients who had low EGF levels were much more likely to develop dementia. Dr. Alice Chen-Plotkin of Udall Center for Parkinson's Research at the University of Pennsylvania School of Medicine says if doctors can determine a patient's dementia risk, it could expedite clinical trials of new therapies.

http://www.thedenverchannel.com/health/28710838/detail.html
CarolynS is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Conductor71 (07-30-2011)

advertisement
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Factors predicting response to dopaminergic treatment for resting tremor of Parkinson imark3000 Parkinson's Disease 1 10-10-2009 08:36 PM


All times are GMT -5. The time now is 04:40 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.